Tigecycline: CMI 50/90 towards 1766 Gram-negative bacilli (3rd generation cephalosporins resistant enterobacteriaceae), Acinetobacter baumannii and Bacteroides fragilis group, University Hospital - Montpellier, 2008-2011

Tigecycline is a new glycylcyclin with a wide spectre including multi-resistant bacteria. Our laboratory tests in routine the in vitro activity of the TGC towards clinically significant isolates of 3rd generation cephalosporins resistant enterobacteriaceae (EC3R), Acinetobacter baumannii and Bactero...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Pathologie biologie (Paris) 2013-12, Vol.61 (6), p.282-285
Hauptverfasser:	Froment Gomis, P, Jean-Pierre, H, Rousseau-Didelot, M-N, Compan, B, Michon, A-L, Godreuil, S
Format:	Artikel
Sprache:	fre
Schlagworte:	Acinetobacter baumannii - drug effects Acinetobacter baumannii - isolation & purification Anti-Bacterial Agents - pharmacology Bacteroides fragilis - drug effects Bacteroides fragilis - isolation & purification Cephalosporin Resistance - drug effects Enterobacteriaceae - drug effects Enterobacteriaceae - isolation & purification France Hospitals, University Microbial Sensitivity Tests Minocycline - analogs & derivatives Minocycline - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!